LJI Research Assistant Professor Cecilia Lindestam Arlehamn, Ph.D., investigates how the immune system’s T cells may contribute to Parkinson’s disease, Alzheimer’s disease, ALS, and even long COVID. Her research has revealed how T cells can target vulnerable neurons in patients with Parkinson’s disease, potentially driving disease onset. Her recent work centers on the question: Could inflammatory T cells lead to ALS and long COVID symptoms as well? Dr. Lindestam Arlehamn will share her findings so far and the next steps in her quest to help patients with these diseases.
